TY  - JOUR 
AU  - Franco Trepat, Eloi
AU  - Alonso Pérez, Ana
AU  - Guillán Fresco, María
AU  - Jorge Mora, Alberto
AU  - Gualillo ., Oreste
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - Gómez Bahamonde, Rodolfo
PY  - 2019
UR  - http://hdl.handle.net/20.500.11940/22781
AB  - Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that...
LA  - eng
KW  - Nicotinamide Phosphoribosyltransferase
KW  - Cytokines
KW  - Animals
KW  - Insulin
KW  - Humans
KW  - Expert Testimony
KW  - Arthritis
KW  - Antirheumatic Agents
KW  - Aging
TI  - Visfatin as a therapeutic target for rheumatoid arthritis.
DO  - 10.1080/14728222.2019.1617274
T2  - Expert opinion on therapeutic targets
M2  - 607
KW  - Visfatin
KW  - IDIS
VL  - 23
ER  -